An academic, sponsor-free audio review of core concepts in colon and rectal surgery. Using the power of A.I., created by Dr. Allen Kamrava, Associate Teaching Faculty at Cedars-Sinai Medical Center, this series is designed for residents, fellows, and practicing surgeons to stay current with concise, evidence-based updates. Covering textbook foundations, landmark trials, and evolving ASCRS guidelines, each episode delivers practical surgical education for the commute, workout, or even to wind down at night. Learn more at https://drkamrava.com/podcast
A rigorous review of Crohn's pharmacotherapy, highlighting the ”Do Nots”: antibiotics and 5-ASAs have limited to no role in luminal disease. We explore the ”Treat to Target” approach and the decision tree for Therapeutic Drug Monitoring (TDM) when patients lose response. The episode also covers perioperative washout periods for biologics and the landmark LIR!C trial, which validates early resection as a primary alternative to medical therapy for limited ileitis.
About
An academic, sponsor-free audio review of core concepts in colon and rectal surgery. Using the power of A.I., created by Dr. Allen Kamrava, Associate Teaching Faculty at Cedars-Sinai Medical Center, this series is designed for residents, fellows, and practicing surgeons to stay current with concise, evidence-based updates. Covering textbook foundations, landmark trials, and evolving ASCRS guidelines, each episode delivers practical surgical education for the commute, workout, or even to wind down at night. Learn more at https://drkamrava.com/podcast
